Cassava Technologies falls after record day, boost from analysts

2020-09-16

  Nasdaq:SAVA fell nearly 10% on Tuesday after rising nearly 90% earlier this week. Analysts raised their ratings after SAVA announced positive news about its Alzheimer’s clinical trial. NASDAQ:SAVA retreated Tuesday after nearly doubling in price on Monday, after Wall Street analysts were bullish on the biotech’s Phase 2B clinicalRead More →

AstraZeneca’s coronavirus vaccine suffered a setback that shows why Big Pharma would rather be safe than sorry. Here’s the good news.

2020-09-09

  U.K.-based pharmaceutical giant AstraZeneca said Tuesday it will suspend clinical trials of a coronavirus vaccine it developed with Oxford University after a British subject fell ill. The decision will affect the company’s just-started so-called Phase 3 trial, which recruited 30,000 volunteers in the U.S. after 10,000 subjects in theRead More →

Chinese stocks pulled lower by pharma, tech losses

2019-09-22

Hong Kong’s Hang Seng Index saw an opening advance quickly fade on Monday, led by AAC Technologies as it extended last week’s losses with a 3.2% drop in morning trading. The Hang Seng HSI, -0.86% recently was off 0.8%. Chinese pharma stocks contributed to the early losses with Sino BiopharmaceuticalRead More →

5 things to know about Hookipa Pharma ahead of its IPO

2019-04-17

Hookipa Pharma Inc., a biotech that’s using arenavirus-based platforms to develop treatments targeting infectious diseases and cancers, priced its initial public offering on the low end of its range late Wednesday. The company said it will sell 6 million shares at $14 each, after previously saying it would offer 6.7Read More →